Lisanne Zijlker on crossing borders on the treatment of melanoma and Merkel Cell Carcinoma
Winan van Houdt shared a post on LinkedIn:
“Congratulations Lisanne Zijlker.
She defended her PhD thesis (crossing borders on the treatment of melanoma and Merkel Cell Carcinoma) with style!
Your PhD team (Michel WJM Wouters, Alexander van Akkooi and me) will miss you.”
Winan van Houdt is a surgical oncologist at Antoni van Leeuwenhoek, specializing in rare cancers such as GIST, soft tissue sarcomas (retroperitoneal, intra-abdominal, and extremity), melanoma, desmoid tumors, and non-melanoma skin cancers. He serves as the Program Coordinator for Rare Cancers at the Netherlands Cancer Institute and chairs the Soft Tissue and Bone Sarcoma Group (STBSG) at the EORTC. Van Houdt is also a member of the Scientific Steering Committee for the Sarcoma Track at ESMO 2024.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023